Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in Recurrent Miscarriage with APS
NCT04624269Phase 4Unknown
- Sponsor
- Shanghai First Maternal and Infant Health Hospital
- Start
- Dec 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hydroxychloroquine in antiphospholipid syndrome (APS) and recurrent miscarriage (RPL), sponsored by Shanghai First Maternal and Infant Health Hospital. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
antiphospholipid syndrome (APS)recurrent miscarriage (RPL)
Beyond the preview
Go deeper on NCT04624269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04624269.